Related references
Note: Only part of the references are listed.Sex-Dependent End-of-Life Mental and Vascular Scenarios for Compensatory Mechanisms in Mice with Normal and AD-Neurodegenerative Aging
Aida Muntsant et al.
BIOMEDICINES (2021)
Specific Phospholipid Modulation by Muscarinic Signaling in a Rat Lesion Model of Alzheimer's Disease
Alberto Llorente-Ovejero et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Deconstructing Alzheimer's Disease: How to Bridge the Gap between Experimental Models and the Human Pathology?
Anais Vignon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer's disease
Ceren Emre et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)
Survival Bias and Crosstalk between Chronological and Behavioral Age: Age- and Genotype-Sensitivity Tests Define Behavioral Signatures in Middle-Aged, Old, and Long-Lived Mice with Normal and AD-Associated Aging
Lydia Gimenez-Llort et al.
BIOMEDICINES (2021)
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Luiz Henrique Medeiros Geraldo et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Caveolin: A New Link Between Diabetes and AD
Andrei Surguchov
CELLULAR AND MOLECULAR NEUROBIOLOGY (2020)
Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
Masaru Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Lysophospholipids and Their G-Coupled Protein Signaling in Alzheimer's Disease: From Physiological Performance to Pathological Impairment
Yining Hao et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Lysophosphatidic acid precursor levels decrease and an arachidonic acid-containing phosphatidylcholine level increases in the dorsal root ganglion of mice after peripheral nerve injury
Yuki Mihara et al.
NEUROSCIENCE LETTERS (2019)
Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease
Alberto Llorente-Ovejero et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Novel function of ceramide for regulation of mitochondrial ATP release in astrocytes
Ji-Na Kong et al.
JOURNAL OF LIPID RESEARCH (2018)
Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer's disease mouse model
Yu Wu et al.
NEUROSCIENCE LETTERS (2017)
Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer's disease
E. Gonzalez de San Roman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems
Luke M. Healy et al.
CURRENT DRUG TARGETS (2016)
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease
Nurgul Aytan et al.
SCIENTIFIC REPORTS (2016)
Hippocampal lipid differences in Alzheimer's disease: a human brain study using matrix-assisted laser desorption/ionization-imaging mass spectrometry
Lakshini H. S. Mendis et al.
BRAIN AND BEHAVIOR (2016)
Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex
Beatriz Garcia-Diaz et al.
BRAIN STRUCTURE & FUNCTION (2015)
Sphingomyelin SM(d18:1/18:0) is Significantly Enhanced in Cerebrospinal Fluid Samples Dichotomized by Pathological Amyloid-β42, Tau, and Phospho-Tau-181 Levels
Therese Koal et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Membrane lipid modifications and therapeutic effects mediated by hydroxydocosahexaenoic acid on Alzheimer's disease
Manuel Torres et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
In vivo type 1 cannabinoid receptor availability in Alzheimer's disease
Rawaha Ahmad et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Type-1 Cannabinoid Receptor Activity During Alzheimer's Disease Progression
Ivan Manuel et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer's Disease
Gaurav Bedse et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease
Raul Gonzalez-Dominguez et al.
JOURNAL OF PROTEOMICS (2014)
Plasma phospholipids identify antecedent memory impairment in older adults
Mark Mapstone et al.
NATURE MEDICINE (2014)
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease
Luke Whiley et al.
NEUROBIOLOGY OF AGING (2014)
Efficient derivation of cortical glutamatergic neurons from human pluripotent stem cells: A model system to study neurotoxicity in Alzheimer's disease
Tandis Vazin et al.
NEUROBIOLOGY OF DISEASE (2014)
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis
Timothy A. Couttas et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Reduced sphingosine kinase-1 and enhanced sphingosine 1-phosphate lyase expression demonstrate deregulated sphingosine 1-phosphate signaling in Alzheimer's disease
Johnatan Ceccom et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)
Lysophospholipids and their receptors in the central nervous system
Ji Woong Choi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Lysophosphatidic acid induces increased BACE1 expression and A beta formation
Jing Shi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2013)
Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer's disease
Yoko Tajima et al.
LIPIDS IN HEALTH AND DISEASE (2013)
Chemical Probes of Endocannabinoid Metabolism
Jacqueline L. Blankman et al.
PHARMACOLOGICAL REVIEWS (2013)
Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus
Raquel Sanchez-Varo et al.
ACTA NEUROPATHOLOGICA (2012)
Autotaxin protects microglial cells against oxidative stress
Rana Awada et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice
Ester Aso et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Plasma and Brain Fatty Acid Profiles in Mild Cognitive Impairment and Alzheimer's Disease
Stephen C. Cunnane et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Comparative Lipidomic Analysis of Mouse and Human Brain with Alzheimer Disease
Robin B. Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
[125I]SD-7015 reveals fine modalities of CB1 cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer's disease
Szabolcs Farkas et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
Matrix Sublimation/Recrystallization for Imaging Proteins by Mass Spectrometry at High Spatial Resolution
Junhai Yang et al.
ANALYTICAL CHEMISTRY (2011)
Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer's disease
Chia-Yu Yeh et al.
ASN NEURO (2011)
Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice
Sara Kalifa et al.
BRAIN RESEARCH (2011)
Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics
Xianlin Han et al.
PLOS ONE (2011)
Elevated Stearoyl-CoA Desaturase in Brains of Patients with Alzheimer's Disease
Giuseppe Astarita et al.
PLOS ONE (2011)
Metabolome in progression to Alzheimer's disease
M. Oresic et al.
TRANSLATIONAL PSYCHIATRY (2011)
S1P metabolism in cancer and other pathological conditions
Weng In Leong et al.
BIOCHIMIE (2010)
Intraneuronal β-Amyloid Accumulation in the Amygdala Enhances Fear and Anxiety in Alzheimer's Disease Transgenic Mice
Judit Espana et al.
BIOLOGICAL PSYCHIATRY (2010)
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease
Hua Cheng et al.
NEUROBIOLOGY OF AGING (2010)
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex
Jasinda H. Lee et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Triple-Transgenic Alzheimer's Disease Mice Exhibit Region-Specific Abnormalities in Brain Myelination Patterns Prior to Appearance of Amyloid and Tau Pathology
Maya K. Desai et al.
GLIA (2009)
Reduced Membrane Lipids in the Cortex of Alzheimer's Disease Transgenic Mice
Jeffrey K. Yao et al.
NEUROCHEMICAL RESEARCH (2009)
Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice
Michael A. Mastrangelo et al.
BMC NEUROSCIENCE (2008)
Endocannabinoid signaling as a synaptic circuit breaker in neurological disease
Istvan Katona et al.
NATURE MEDICINE (2008)
Lysophosphatidic acid stimulates astrocyte proliferation through LPA(1)
Shinya Shano et al.
NEUROCHEMISTRY INTERNATIONAL (2008)
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
T. Rubino et al.
NEUROPHARMACOLOGY (2008)
Interactions between neural membrane glycerophospholipid and sphingolipid mediators: A recipe for neural cell survival or suicide
Akhlaq A. Farooqui et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Cannabinoids potentiate emotional learning plasticity in neurons of the medial prefrontal cortex through basolateral amygdala inputs
Steven R. Laviolette et al.
JOURNAL OF NEUROSCIENCE (2006)
Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging
Michael P. Harms et al.
EXPERIMENTAL NEUROLOGY (2006)
Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients
Ken Umemura et al.
NEUROSCIENCE LETTERS (2006)
The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins
JE Lauckner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Intraneuronal Aβ causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice
LM Billings et al.
NEURON (2005)
Prevention of Alzheimer's disease pathology by cannabinoids:: Neuroprotection mediated by blockade of microglial activation
BG Ramírez et al.
JOURNAL OF NEUROSCIENCE (2005)
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
Jared Ehrhart et al.
JOURNAL OF NEUROINFLAMMATION (2005)
CB1 cannabinoid receptors and on-demand defense against excitotoxicity
G Marsicano et al.
SCIENCE (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Direct tissue analysis using matrix-assisted laser desorption/ionization mass spectrometry: practical aspects of sample preparation
SA Schwartz et al.
JOURNAL OF MASS SPECTROMETRY (2003)
Microglial activation state and lysophospholipid acid receptor expression
CS Tham et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
S Oddo et al.
NEUROBIOLOGY OF AGING (2003)
Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling
V Colangelo et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Increased Aβ peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease
AE Roher et al.
BIOCHEMISTRY (2002)
Inflammation in neurodegenerative disease - A double-edged sword
T Wyss-Coray et al.
NEURON (2002)
A potent protective role of lysophospholipids against global cerebral ischemia and glutamate excitotoxicity in neuronal cultures
N Blondeau et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2002)
Regulation of neuronal cytoskeleton by lysophosphatidic acid: role of GSK-3
CL Sayas et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Involvement of CB1 cannabinoid receptors in emotional behaviour
M Martin et al.
PSYCHOPHARMACOLOGY (2002)
Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells
T Möller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment
JA Conquer et al.
LIPIDS (2000)
Neuroscience: Breaking down scientific barriers to the study of brain and mind
ER Kandel et al.
SCIENCE (2000)
Essential fatty acids and the brain: possible health implications
KA Youdim et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2000)
Share Paper
